Q3 FY2026 · ended Sep 30, 2026 · Revenue $567.78M, +0.1% YoY · Filed Nov 5, 2026
Teleflex Incorporated (TFX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $567.8 million and net income of $927.4 million. Free cash flow was $74.7 million. As of Sep 30, 2026 it held $454.1 million in cash and investments and $1.8 billion in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TFX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 96943
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 28, 2025 |
|---|---|---|---|---|---|
| Revenue | $567.8M | $570.3M | $548.3M | $569.0M | $566.9M |
| Operating income | $105.4M | $72.8M | $20.2M | $13.9M | -$62.4M |
| Net income | $927.4M | $99.7M | -$8.2M | -$714.3M | -$408.9M |
| Diluted EPS | $22.28 | $2.28 | -$0.18 | -$16.15 | -$9.24 |
| Operating cash flow | $96.3M | $91.9M | $46.7M | $86.4M | $19.6M |
| Free cash flow | $74.7M | $77.9M | $27.9M | $62.6M | $69,000 |
| Total assets | $6.3B | $6.8B | $6.8B | $6.9B | $7.9B |
| Total liabilities | $2.9B | $3.9B | $3.7B | $3.8B | $4.1B |
| Stockholders' equity | $3.5B | $2.9B | $3.1B | $3.1B | $3.8B |
| Cash and investments | $454.1M | $326.6M | $339.2M | $411.4M | $389.9M |
| Total debt | $1.8B | $3.0B | $2.7B | $2.7B | $2.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 9, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Other events
|
Aug 7, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
All 1007 Teleflex Incorporated SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.